Asahi Kasei (TSE:3407) Full Year 2025 Results
Key Financial Results
- Revenue: JP¥3.04t (up 9.1% from FY 2024).
- Net income: JP¥135.0b (up 208% from FY 2024).
- Profit margin: 4.4% (up from 1.6% in FY 2024). The increase in margin was driven by higher revenue.
- EPS: JP¥97.94 (up from JP¥31.60 in FY 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Asahi Kasei EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 15%.
The primary driver behind last 12 months revenue was the Material segment contributing a total revenue of JP¥1.39t (46% of total revenue). Notably, cost of sales worth JP¥2.08t amounted to 68% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to JP¥746.3b (91% of total expenses). Explore how 3407's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan.
Performance of the Japanese Chemicals industry.
The company's share price is broadly unchanged from a week ago.
Valuation
Our analysis of these results suggests Asahi Kasei may be undervalued based on 6 important criteria we look at. To access our thorough examination of analyst consensus click here and discover the expected future direction of the company.
Valuation is complex, but we're here to simplify it.
Discover if Asahi Kasei might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.